T. Moller (Leiden, Netherlands), C. Gratziou (Athens, Greece)
A proof-of-concept randomized-controlled trial of omalizumab in patients with severe difficult to control nonatopic asthma G. Garcia, A. Magnan, R. Chiron, P.O. Girodet, V. Le Gros, M. Humbert (Clamart, Nantes, Montpellier, Bordeaux, Rueil-Malmaison, France)
| |
Observational study in severe asthmatic patients after discontinuation of omalizumab for good asthma control M. Molimard, V. Le Gros, I. Bourdeix (Bordeaux, Rueil-Malmaison, France)
| |
Rhinovirus infection activates coagulation through eosinophilic airway inflammation C. Majoor, P. Kamphuisen, M. van de Pol, J. Meijers, T. van der Poll, A. Böing, R. Nieuwland, S. Johnston, P. J. Sterk, E. Bel, R. Lutter, K. van der Sluijs (Amsterdam, Groningen, Netherlands; London, United Kingdom)
| |
Exhaled air volatile organic compounds and eosinophilic airway inflammation in asthma A.H. Wagener, A.H. Zwinderman, R. Lutter, S. de Koning, H.G. Janssen, R.G. Knowles, A. Sousa, E.H. Bel, P.J. Sterk (Amsterdam, Netherlands; Mönchengladbach, Germany; Stevenage, United Kingdom)
| |
IgE-autoantibodies and adipokines in patients with bronchial asthma and obesity A. Konishcheva, V. Gervazieva, E. Lavrentyeva (Moscow, Russian Federation)
| |
Effect of bariatric surgery on asthma: 3 months follow-up A. van Huisstede, M. Castro Cabezas, H. Zengerink, R. Luitwieler, C. Taube, P.S. Hiemstra, G.J. Braunstahl (Rotterdam, Leiden, Netherlands)
| |
Substitution of vitamin D in patients with moderate to severe persistent asthma: A randomized, placebo-controlled pilot study A. Breitenbücher, U. Voit, D. Miedinger, J.D. Leuppi, R. Krapf (Bruderholz, Basel, Switzerland)
| |
BTS Difficult Asthma Registry: Effect of omalizumab dosing table expansion on size of population of severe persistent allergic asthma patients potentially eligible for omalizumab therapy L. Heaney, A. Menzies-Gow, A. Mansur, C. Brightling, R. Niven, R. Chaudhuri, C. Bucknall, A. Radwan (London, Birmingham, Glasgow, Frimley/Camberley, United Kingdom)
| |